IMMUNITYBIO INC (IBRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IBRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IBRX | Independent Director | 52 | ["Experienced physician and surgeon","Medical educator","Published scientific author","Health technology entrepreneur and innovator","Operating Partner at DCVC Management Co, LLC","Former Adjunct Professor of Surgery at University of Toronto","Distinguished Visiting Professor at Toronto Metropolitan University","Associate Scientist at the Li Ka Shing Knowledge Institute","Founder and former Executive Director of the Biomedical Zone","Managed a life sciences tech transfer portfolio at the University of Oxford and the UK National Health Service","Healthcare innovation expert to various Canadian government entities","Advisor to the Canadian Medical Association and the Canadian Space Agency","Certified Independent Corporate Director in the U.S. (NACD.DC) and Canada (ICD.D)"] | ["Compensation","Related Party Transaction","Audit"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Maxwell has served as a member of the Board since March 2021. She is an experienced physician and surgeon, having managed her own head and neck surgical practice since 2006. She is a medical educator, a published scientific author, and a health technology entrepreneur and innovator. As of March 2022, she is an Operating Partner at DCVC Management Co, LLC, a deep tech venture capital investment fund. She was previously an Adjunct Professor of Surgery at University of Toronto, a Distinguished Visiting Professor at Toronto Metropolitan University, and an Associate Scientist at the Li Ka Shing Knowledge Institute in Toronto. She is the Founder and former Executive Director of the Biomedical Zone at Toronto Metropolitan University, Canada s premier hospital-embedded medical technology incubator for early-stage digital health and medical technology companies, and has guided a wide variety of startup companies through clinical development, capitalization and commercialization. She has also managed a life sciences tech transfer portfolio at the University of Oxford and the UK National Health Service, executing patent strategy, spin-out company formation, and early-stage capital raising. She has also served as a healthcare innovation expert to various Canadian federal, provincial, and local government entities, as a member of the Department Audit Committee of the Public Health Agency of Canada, and as an advisor to the Canadian Medical Association and the Canadian Space Agency. She currently serves on the board of directors of United Therapeutics Corporation (Nasdaq:UTHR). Dr. Maxwell earned an A.B. with honors from Harvard University, an M.D. from Yale University School of Medicine, and an M.B.A. from the Saïd Business School at the University of Oxford. Dr. Maxwell is a certified Independent Corporate Director in both the U.S. (NACD.DC) and Canada (ICD.D). We believe Dr. Maxwell is qualified to serve as a member of the Board based on her extensive medical and scientific knowledge and experience, public company governance experience, and her experience advising and cultivating companies in the health technology industry.